142 related articles for article (PubMed ID: 36948487)
1. Psychiatric Adverse Effects of Montelukast-A Nationwide Cohort Study.
Jordan A; Toennesen LL; Eklöf J; Sivapalan P; Meteran H; Bønnelykke K; Ulrik CS; Stæhr Jensen JU
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2096-2103.e1. PubMed ID: 36948487
[TBL] [Abstract][Full Text] [Related]
2. The Risk of Neuropsychiatric Adverse Events With Use of Leukotriene Receptor Antagonists in Patients With Asthma: Analysis of Korea's National Health Insurance Sharing Service Database.
Kim JH; Lee H; Jeong D; Lee JH; Kwon HS; Song WJ; Cho YS; Kim YJ; Shin YW; Kim TB
J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3690-3699.e7. PubMed ID: 37660732
[TBL] [Abstract][Full Text] [Related]
3. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation.
Paljarvi T; Forton J; Luciano S; Herttua K; Fazel S
JAMA Netw Open; 2022 May; 5(5):e2213643. PubMed ID: 35608857
[TBL] [Abstract][Full Text] [Related]
5. Treatment with montelukast and antidepressive medication-a symmetry analysis.
Winkel JS; Damkier P; Hallas J; Henriksen DP
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1409-1415. PubMed ID: 30136330
[TBL] [Abstract][Full Text] [Related]
6. Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 coding.
Apata J; Lyons JG; Bradley MC; Ma Y; Kempner ME; Kim I; Eworuke E; Pennap D; Mosholder A
J Asthma; 2024 Jul; 61(7):653-662. PubMed ID: 38064517
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug reactions affecting treatment adherence in first-line treatment of asthma: An observational study.
Erdem SB; Nacaroglu HT; Can D
Allergol Immunopathol (Madr); 2023; 51(2):11-16. PubMed ID: 36916083
[TBL] [Abstract][Full Text] [Related]
8. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.
Wechsler ME; Finn D; Gunawardena D; Westlake R; Barker A; Haranath SP; Pauwels RA; Kips JC; Drazen JM
Chest; 2000 Mar; 117(3):708-13. PubMed ID: 10712995
[TBL] [Abstract][Full Text] [Related]
9. Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case-Control Study.
Glockler-Lauf SD; Finkelstein Y; Zhu J; Feldman LY; To T
J Pediatr; 2019 Jun; 209():176-182.e4. PubMed ID: 30905424
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene receptor antagonists for eczema.
Ferguson L; Futamura M; Vakirlis E; Kojima R; Sasaki H; Roberts A; Mori R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011224. PubMed ID: 30343498
[TBL] [Abstract][Full Text] [Related]
11. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
Laviolette M; Malmstrom K; Lu S; Chervinsky P; Pujet JC; Peszek I; Zhang J; Reiss TF
Am J Respir Crit Care Med; 1999 Dec; 160(6):1862-8. PubMed ID: 10588598
[TBL] [Abstract][Full Text] [Related]
12. The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients.
Di Salvo E; Patella V; Casciaro M; Gangemi S
Pulm Pharmacol Ther; 2020 Feb; 60():101875. PubMed ID: 31837440
[TBL] [Abstract][Full Text] [Related]
13. Montelukast-induced adverse drug reactions: a review of case reports in the literature.
Calapai G; Casciaro M; Miroddi M; Calapai F; Navarra M; Gangemi S
Pharmacology; 2014; 94(1-2):60-70. PubMed ID: 25196099
[TBL] [Abstract][Full Text] [Related]
14. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
Bateman ED; Goehring UM; Richard F; Watz H
J Allergy Clin Immunol; 2016 Jul; 138(1):142-149.e8. PubMed ID: 26915674
[TBL] [Abstract][Full Text] [Related]
15. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.
Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R
Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233
[TBL] [Abstract][Full Text] [Related]
16. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study.
Hauser T; Mahr A; Metzler C; Coste J; Sommerstein R; Gross WL; Guillevin L; Hellmich B
Thorax; 2008 Aug; 63(8):677-82. PubMed ID: 18276721
[TBL] [Abstract][Full Text] [Related]
17. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
[TBL] [Abstract][Full Text] [Related]
18. In brief: Neuropsychiatric events with montelukast.
Med Lett Drugs Ther; 2020 May; 62(1597):65. PubMed ID: 32555111
[No Abstract] [Full Text] [Related]
19. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
20. Montelukast for prevention and treatment of asthma exacerbations in adults: Systematic review and meta-analysis.
Zhang HP; Jia CE; Lv Y; Gibson PG; Wang G
Allergy Asthma Proc; 2014; 35(4):278-87. PubMed ID: 24992547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
